Amyloidosis is frequently undetected in patients with rheumatoid arthritis

References

• Kobayashi H, Tada S, Fuchigami T, Okuda Y, Takasugi K, Matsumoto T, Iida M, Aoyagi K, Iwashita A, Daimaru Y, Fujishima M. Secondary amyloidosis in patients with rheumatoid arthritis: diagnostic and prognostic value of gastroduodenal biopsy. Br J Rheumatol 1996; 35: 44–49
   PubMedGoogle Scholar
• Husby G. Amyloidosis. Semin Arthritis Rheum 1992; 22: 67–82
   PubMedGoogle Scholar
• El Mansoury T M, Hazenberg B P, El Badawy S A, Ahmed A H, Bijzet J, Limburg P C, van Rijswijk M H. Screening for amyloid in subcutaneous fat tissue of Egyptian patients with rheumatoid arthritis: clinical and laboratory characteristics. Ann Rheum Dis 2002; 61: 42–47
   PubMed Web of Science ®Google Scholar
• Ishii W, Matsuda M, Nakamura A, Nakamura N, Suzuki A, Ikeda S. Abdominal fat aspiration biopsy and genotyping of serum amyloid A contribute to early diagnosis of reactive AA amyloidosis secondary to rheumatoid arthritis. Intern Med 2003; 42: 800–805
   PubMed Web of Science ®Google Scholar
• Gomez-Casanovas E, Sanmarti R, Sole M, Canete J D, Munoz-Gomez J. The clinical significance of amyloid fat deposits in rheumatoid arthritis: a systematic long-term followup study using abdominal fat aspiration. Arthritis Rheum 2001; 44: 66–72
   PubMedGoogle Scholar
• Barile L F, Ariza R A, Muci H, Pizarro S C, Fraga A M, Lavalle C M, Garcia R T, Lescano D, Barrios R, Frati A M. Tru-cut needle biopsy of subcutaneous fat in the diagnosis of secondary amyloidosis in rheumatoid arthritis. Arch Med Res 1993; 24: 189–192
   PubMedGoogle Scholar
• Kuroda T, Tanabe N, Sakatsume M, Nozawa S, Mitsuka T, Ishikawa H, Tohyama C, Nakazono K, Murasawa A, Nakano M, Gejyo F. Comparison of gastroduodenal, renal and abdominal fat biopsies for diagnosing amyloidosis in rheumatoid arthritis. Clin Rheumatol 2002; 21: 123–128
   PubMed Web of Science ®Google Scholar
• Ramirez G, Lambert R, Bloomer H A. Renal pathology in patients with rheumatoid arthritis. Nephron 1981; 28: 124–126
   PubMed Web of Science ®Google Scholar
• Boers M, Croonen A M, Dijkmans B A, Breedveld F C, Eulderink F, Cats A, Weening J J. Renal findings in rheumatoid arthritis: clinical aspects of 132 necropsies. Ann Rheum Dis 1987; 46: 658–663
   PubMed Web of Science ®Google Scholar
• Suzuki A, Ohosone Y, Obana M, Mita S, Matsuoka Y, Irimajiri S, Fukuda J. Cause of death in 81 autopsied patients with rheumatoid arthritis. J Rheumatol 1994; 21: 33–36
   PubMed Web of Science ®Google Scholar
• Teilum G, Lindahl A. Frequency and significance of amyloid changes in rheumatoid arthritis. Acta Med Scand 1954; 149: 449–455
   PubMedGoogle Scholar
• Prior P, Symmons D P, Scott D L, Brown R, Hawkins C F. Cause of death in rheumatoid arthritis. Br J Rheumatol 1984; 23: 92–99
   PubMedGoogle Scholar
• Kvalvik A G, Jones M A, Symmons D P. Mortality in a cohort of Norwegian patients with rheumatoid arthritis followed from 1977 to 1992. Scand J Rheumatol 2000; 29: 29–37
   PubMed Web of Science ®Google Scholar
• Laakso M, Mutru O, Isomaki H, Koota K. Mortality from amyloidosis and renal diseases in patients with rheumatoid arthritis. Ann Rheum Dis 1986; 45: 663–667
   PubMed Web of Science ®Google Scholar
• Martinez M S, Garcia-Monforte A, Rivera J. Survival study of rheumatoid arthritis patients in Madrid (Spain). A 9-year prospective follow-up. Scand J Rheumatol 2001; 30: 195–198
   PubMed Web of Science ®Google Scholar
• Lehtinen K, Isomaki H. Intramuscular gold therapy is associated with long survival in patients with rheumatoid arthritis. J Rheumatol 1991; 18: 524–529
   PubMed Web of Science ®Google Scholar
• Mutru O, Koota K, Isomaki H. Causes of death in autopsied RA patients. Scand J Rheumatol 1976; 5: 239–240
   PubMed Web of Science ®Google Scholar
• Koivuniemi R, Leirisalo-Repo M, Suomalainen R, Piirainen H, Paimela L. Infectious causes of death in patients with rheumatoid arthritis: an autopsy study. Scand J Rheumatol 2006; 35: 273–276
   PubMed Web of Science ®Google Scholar
• Steinbrocker O, Trager C H, Betteman R C. Therapeutic criteria in rheumatoid arthritis. JAMA 1949; 140: 659–662
   PubMed Web of Science ®Google Scholar
• Browning M J, Banks R A, Tribe C R, Hollingworth P, Kingswood C, Mackenzie J C, Bacon P A. Ten years' experience of an amyloid clinic – a clinicopathological survey. Q J Med 1985; 54: 213–227
   PubMedGoogle Scholar
• Wright J R, Calkins E. Clinical-pathologic differentiation of common amyloid syndromes. Medicine (Baltimore) 1981; 60: 429–448
   PubMed Web of Science ®Google Scholar
• Gillmore J D, Lovat L B, Persey M R, Pepys M B, Hawkins P N. Amyloid load and clinical outcome in AA amyloidosis in relation to circulating concentration of serum amyloid A protein. Lancet 2001; 358: 24–29
   PubMed Web of Science ®Google Scholar
• Gertz M A, Kyle R A. Secondary systemic amyloidosis: response and survival in 64 patients. Medicine (Baltimore) 1991; 70: 246–256
   PubMed Web of Science ®Google Scholar
• Cohen A S, Comerford F R. Laboratory studies in the diagnosis of rheumatoid arthritis. Med Clin North Am 1968; 52: 539–548
   PubMedGoogle Scholar
• Tiitinen S, Kaarela K, Helin H, Kautiainen H, Isomaki H. Amyloidosis – incidence and early risk factors in patients with rheumatoid arthritis. Scand J Rheumatol 1993; 22: 158–161
   PubMed Web of Science ®Google Scholar
• Wiland P, Wojtala R, Goodacre J, Szechinski J. The prevalence of subclinical amyloidosis in Polish patients with rheumatoid arthritis. Clin Rheumatol 2004; 23: 193–198
   PubMedGoogle Scholar
• Lachmann H J, Goodman H J, Gilbertson J A, Gallimore J R, Sabin C A, Gillmore J D, Hawkins P N. Natural history and outcome in systemic AA amyloidosis. N Engl J Med 2007; 356: 2361–2371
   PubMed Web of Science ®Google Scholar
• Myllykangas-Luosujarvi R, Aho K, Kautiainen H, Hakala M. Amyloidosis in a nationwide series of 1666 subjects with rheumatoid arthritis who died during 1989 in Finland. Rheumatology (Oxford) 1999; 38: 499–503
   PubMed Web of Science ®Google Scholar
• Welsh T S, Kaplan J. The role of postmortem examination in medical education. Mayo Clin Proc 1998; 73: 802–805
   PubMedGoogle Scholar
• Tiitinen S, Kaarela K, Filipowicz-Sosnowska A, Maczynska-Rusiniak B, Lehtinen K, Leirisalo-Repo M, Paimela L, Koskimies S. HLA typing and seropositivity in Finnish and in Polish patients with rheumatoid arthritis and amyloidosis. Clin Rheumatol 1992; 11: 265–268
   PubMedGoogle Scholar
• Laiho K, Tiitinen S, Kaarela K, Helin H, Isomaki H. Secondary amyloidosis has decreased in patients with inflammatory joint disease in Finland. Clin Rheumatol 1999; 18: 122–123
   PubMed Web of Science ®Google Scholar
• Dhillon V, Woo P, Isenberg D. Amyloidosis in the rheumatic diseases. Ann Rheum Dis 1989; 48: 696–701
   PubMed Web of Science ®Google Scholar
• Berglund K, Thysell H, Keller C. Results, principles and pitfalls in the management of renal AA-amyloidosis; a 10–21 year followup of 16 patients with rheumatic disease treated with alkylating cytostatics. J Rheumatol 1993; 20: 2051–2057
   PubMed Web of Science ®Google Scholar
• Fernandez-Nebro A, Tomero E, Ortiz-Santamaria V, Castro M C, Olive A, de Haro M, Portales R G, Gonzalez-Mari M V, Laffon A, Garcia-Vicuna R. Treatment of rheumatic inflammatory disease in 25 patients with secondary amyloidosis using tumor necrosis factor alpha antagonists. Am J Med 2005; 118: 552–556
   PubMed Web of Science ®Google Scholar